Eczema Prevention Study
| Status: | Completed |
|---|---|
| Conditions: | Psoriasis, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/2/2016 |
| Start Date: | November 2006 |
| End Date: | November 2010 |
| Contact: | Maureen Keene |
| Phone: | 503-228-7350 |
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
The purpose of this study is to determine whether early use of a bland emollient in
newborns, prior to the clinical signs of skin disease, will delay the onset or prevent the
development of atopic dermatitis.
newborns, prior to the clinical signs of skin disease, will delay the onset or prevent the
development of atopic dermatitis.
All neonates will be treated with Cetaphil cream starting within 1 week of birth. All
neonates enrolled will have an increased risk of developing atopic dermatitis because they
have a family history of either asthma, hay fever, or atopic dermatitis. These neonates will
then be followed for 2 years for the signs and symptoms of atopic dermatitis.
neonates enrolled will have an increased risk of developing atopic dermatitis because they
have a family history of either asthma, hay fever, or atopic dermatitis. These neonates will
then be followed for 2 years for the signs and symptoms of atopic dermatitis.
Inclusion Criteria:
- at least one parent diagnosed with Atopic Dermatitis
- one parent or sibling with hayfever or asthma
Exclusion Criteria:
- newborns with dermatitis at birth
- newborns born greater than four weeks prematurely
- newborns with medical problems necessitating prolonged hospitalization
- newborns diagnosed with any immune deficiency syndrome
We found this trial at
1
site
Click here to add this to my saved trials
